Zepbound 2.5 MG/0.5 ML pen 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FR37D
Awardee
Awarding agency
Obligated
$18,247

Award facts

Contract value 100% obligated
$18,247.49 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 24, 2026, for Zepbound (semaglutide) 2.5 mg/0.5 mL injectable pens, with a ceiling value of $18,247.49 and ultimate completion date of April 27, 2026.

Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier serving Defense Health Agency and military medical facilities globally.

Quick answers

Who was awarded contract SPE2DR26FR37D?

SPE2DR26FR37D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2026.

How much is contract SPE2DR26FR37D worth?

The government has obligated $18,247 on SPE2DR26FR37D.

Is contract SPE2DR26FR37D an order under another contract?

Yes. SPE2DR26FR37D is a delivery order under SPE2DR25D2003, an indefinite delivery contract.

Was contract SPE2DR26FR37D competed?

The extent of competition for SPE2DR26FR37D was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award